Evaluation of Oxidative Stress after Repeated Intravenous Iron Supplementation

REFERENCES

• Fisher, J W. Mechanism of the anemia of chronic renal failure. Nephron 1980, 25, 106–111. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Eschenbach, J W.; Adamson, J W. Anemia of end stage renal disease (ESRD). Kidney Int. 1985, 28, 1–5.
   PubMedGoogle Scholar
• Eckardt, K U. Pathophysiology of renal anemia. Clin. Nephrol. 2000, 53 (S1), S2–S8. [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Fishbane, S.; Frei, G L.; Maesuka, J. Reduction of human erythropoietin dose by the use of chronic intravenous iron supplementation. Am. J. Kidney Dis. 1995, 7, 204–207.
   Google Scholar
• Tarng, D C.; Chen, T W.; Huang, T P. Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients. Am. J Nephrol. 1995, 15, 230–237. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• National Kidney Foundation-Dialysis Outcomes Quality Initiative. Clinical guide lines for the treatment of anemia of chronic renal failure. Eknoyanv G., Ed.; III Iron support. Am. J. Kidney Dis. 1997, 30 (4 Suppl 3), S192–S240. [CSA]
   Google Scholar
• Deicher, R.; Horl, W H. Intravenous iron: theiatrogenic kick to lose control over oxygen? Kidney Blood Press. Res. 2002, 25 (5), 284–288. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Mimic-Oka, J.; Simic, T.; Djukanovic, Lj.; Stefanovski; Ramic, Z. Glutathione and its associated enzymes in peripheral blood cells in different stages of chronic renal insufficiency. Amino Acids 1992, 2, 215–224.
   PubMedGoogle Scholar
• Mimic-Oka, J.; Simic, T.; Ekmescic, V.; Dragicevic, P. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure. Clin. Nephrol. 1995, 44 (1), 44–48. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Mimic-Oka, J.; Simic, T.; Djukanovic, Lj.; Reljic, Z.; Davicevic, Z. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin. Nephrol. 1999, 4, 223–241.
   Google Scholar
• Jackson, P.; Loughrey, C M.; Lightbody, J H.; Mc Namel, P T.; Young, I S. Effects of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin. Chem. 1995, 41, 1135–1138. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tetta, C.; Biasoli, S.; Schiavon, R.; Inguaggiato, P.; David, S.; Panichi, V.; Wratten, M L. An overview of hemodialysis and oxidant stress. Blood Purif. 1999, 17, 118–126. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Luciak, M.; Trznadel, K. Free oxygen species metabolism during hemodialysis with different membranes. Nephrol. Dial. Transplant. 1991, S3, 66–70.
   Google Scholar
• Grune, T.; Sommerburg, O.; Siems, W G. Oxidative stress in anemia. Clin. Nephrol. 2000, 53 (S1), S18–S23. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Halliwell, B.; Gutteridge, J M.C. Oxidative stress and antioxidant protection: some special cases. In Free Radicals in Biology and Medicine. Halliwell, B., Gutteridge, J M.C., Eds.; Oxford University Press: New York, 2000; 485–499.
   Google Scholar
• Ludat, K.; Sommerburg, O.; Grune, T.; Siems, W G.; Riedel; Hampl, H. Oxidation parameters in complete correction of renal anemia. Clin. Nephrol. 2000, 53 (S1), 530–535.
   Google Scholar
• Mimic-Oka, J.; Simic, T.; Djukanovic, Lj. Epoetin treatment improves red blood cell and plasma antioxidant capacity in hemodialysis patients. Ren. Fail. 2002, 24 (1), 77–87. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lim, P S.; Wei, Y H.; Yu, Y L.; Kho, B. Enhanced oxidative stress in hemodialysis patients receiving intravenous iron therapy. Nephrol. Dial. Transplant. 1999, 14, 2680–2687. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rooyakkers, T M.; Stroes, E S.; Kooistra, M P.; van Faassen, E E.; Hider, R C.; Rabelink, T J.; Marx, J J. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur. J. Clin. Investig. 2002, S1, 9–16. [CROSSREF]
   Google Scholar
• Misra, H P.; Fridovich, I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247, 3170–3175. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gunzler, W A.; Kremers, H.; Flohe, L. An improved coupled test procedure for glutathione peroxidase in blood. Z. Klin. Chem. Klin. Biochem. 1974, 12, 444–448. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Dousset, J C.; Trouilh, M.; Foglietti, M J. Plasma malonaldehyde levels during myocardial infarction. Clin. Chim. Acta 1983, 129, 319–322. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jocelyn, P C. Spectrophotometric assay of thiols. Methods Enzymol. 1987, 143, 44–67. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Elman, G L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 74, 443–450. [CROSSREF]
   Google Scholar
• Levine, R L.; Williams, J A.; Stadtman, E R.; Shacter, E. Carbonyl assay determination of oxidatively modified proteins. Methods Enzymol. 1994, 233, 346–357. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cavdar, C.; Temiz, A.; Yenicerioglu; Caliskan, S.; Celik, A.; Sifil, A.; Onvural, B.; Camsari, T. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients. Scand. J. Urol. Nephrol. 2003, 37 (1), 77–82. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tovbin, D.; Mazor, D.; Vorobiov, M.; Chaimovitz, C.; Meyerstein, N. Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation. Am. J. Kidney Dis. 2002, 40 (5), 1005–1012. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Drüeke, T.; Witko-Sarsat, V.; Massy, Z.; Descamps-Latscha, B.; Guerrin, A P.; Marchais, S J.; Gausson, V.; London, G M. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002, 106, 2212–2217. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Roob, J M.; Koschsorur, G.; Tiran, A.; Horina, J H.; Holzer, H.; Winklhofer-Roob, B M. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J. Am. Soc. Nephrol. 2000, 11, 539–549. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Esposito, B P.; Breuer, W.; Slotki, I.; Cabantchik, Z I. Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients. Eur. J. Clin. Investig. 2002, 32 (S1), 42–49. [CROSSREF]
   PubMedGoogle Scholar
• Davies, K J.A. Protein damage and degradation by oxygen free radicals. II Modification of amino acids. J. Biol. Chem. 1987, 262, 9902–9907. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar